bioRxivNeurosciencePreprint
Myelin pathology is a key feature of X-linked Dystonia Parkinsonism
Priya PrakashiD, Kerry C. LimbergiD, Weimin ZhangiD, Yu ZhaoiD, Klaudia Flóra Laborc, Anna O'Keeffe, Bryanna C. Vilnaigre, Heather L. Appleby, Michael R. O’DeaiD, Cara Fernandez‐Cerado, G. Paul Legarda, Michelle Ann C. SyiD, Edwin L. Muñoz, Mark Angelo C. AngiD, Cid Czarina E. DiestaiD, Justin Han, Ean P. Norenberg, Ellen B. PenneyiD, D. Cristopher BraggiD, Adam C. MariD, Ran BroshiD, Jef D. BoekeiD, Shane Antony LiddelowiD
Abstract
X-linked Dystonia-Parkinsonism (XDP) is a progressive, adult-onset neurodegenerative movement disorder that predominantly affects males of Filipino descent1-3. The disease is caused by the insertion of a SINE-VNTR-Alu subfamily F (SVA_F) retrotransposon within an intron of the TATA-box binding protein-associated factor 1 (TAF1) gene4. A major barrier to understanding the pathophysiology of XDP has been the lack of relevant animal models. Here, we introduce a novel conditional humanized XDP mouse model harboring a hybrid mouse-human Taf1/TAF1 gene (hyTAF1) containing the pathogenic SVA_F insertion. We activated the hyTAF1 in Nestin+ neural progenitor cells and found that the resulting XDP male mice recapitulate features of the human disease including severe motor impairment, striatal atrophy, and reactive gliosis. Transcriptomic, histological, and electron microscopy analysis revealed a dramatic reduction in oligodendrocyte lineage cells and widespread myelin disruption. Consistent with these findings, postmortem brain tissue from XDP patients revealed similar myelin pathology, including near-complete loss of myelin in parts of the medial prefrontal cortex. Together, these results identify oligodendrocyte dysfunction and myelin loss as previously unrecognized contributors to XDP pathogenesis, providing new mechanistic insight into this debilitating disorder.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism
Laura D’Ignazio, Ricardo de Souza Jacomini, … Jennifer A. Erwin·eNeuroPeer-reviewed·Jul 1, 2022
- Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly
Tatsiana Aneichyk, William T. J. Hendriks, … Michael E. Talkowski·CellPeer-reviewed·Jan 1, 2018
- Genome writing to dissect consequences of SVA retrotransposon disease X-Linked Dystonia Parkinsonism
Weimin Zhang, Yu Zhao, … Jef D. Boeke·bioRxiv·Oct 7, 2025
- ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP)
Jimi L. Rosenkrantz, Sanaz Raghib, … Frank M. J. Jacobs·bioRxiv·Oct 20, 2023
- Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat
Lindsey N. Campion, Alan Mejia Maza, … Vanessa Chantal Wheeler·Acta Neuropathologica CommunicationsPeer-reviewed·Apr 8, 2022
- MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonism
Alan Mejia Maza, Madison Hincher, … Vanessa Chantal Wheeler·bioRxiv·May 14, 2025